Information about Groupe Tete Pharmaceutical
My details
*
*
*
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

Groupe Tete Pharmaceutical (SRL)

Company information
Status
Active
Enterprise number
BE0542.600.182
VAT liability
Yes
Established
29-11-2013
Last balance sheet year
2023
Company size
Small 0 FTE
Principal activity
Manufacture of basic pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Groupe Tete Pharmaceutical

{{translate("download")}}

Publications in the Belgian Official Journal from Groupe Tete Pharmaceutical

Date Publication
13-02-2025 Modification Legal Form - Denomination - Resignations, Appointments (FR)
23-02-2024 Resignations, Appointments (FR)
12-03-2020 Registered Office (FR)
27-11-2019 Resignations, Appointments (FR)
03-12-2013 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Groupe Tete Pharmaceutical?
The VAT number of Groupe Tete Pharmaceutical is BE0542600182.
When was Groupe Tete Pharmaceutical founded?
Groupe Tete Pharmaceutical was founded on 29-11-2013.
What is the address of Groupe Tete Pharmaceutical?
The current registered office of Groupe Tete Pharmaceutical is located at Rue de l'Evêché 8, 1400 Nivelles.
When was the last time Groupe Tete Pharmaceutical filed their annual financial statements?
The most recent financial statements of Groupe Tete Pharmaceutical were filed on 27-08-2024. You can view them here.
How many employees does Groupe Tete Pharmaceutical have?
There are currently no employees working at Groupe Tete Pharmaceutical or no workforce information is available.
What is the annual turnover of Groupe Tete Pharmaceutical?
At the time of its most recent financial statements, Groupe Tete Pharmaceutical did not publish any turnover figures. Groupe Tete Pharmaceutical reported a gross margin of €93,096.92.